Activation and control of CNS innate immune responses in health and diseases: A balancing act finely tuned by neuroimmune regulators (NIReg)

CNS and Neurological Disorders - Drug Targets

Volumn 10, Issue 1, 2011, Pages 25-43

  Hoarau, Jean Jacques ^a   Krejbich Trotot, Pascale ^a   Jaffar Bandjee, Marie Christine ^a,b   Das, Trina ^a   Thon Hon, Gerard Vincent ^a   Kumar, Shiril ^a   Neal, Jim W ^c   Gasque, Philippe ^a  

^a UNIVERSITÉ DE LA RÉUNION   (France)

^b CHR Felix Guyon   (France)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Apoptotic; CNS; DAMP; Innate immunity; Necrotic; NIReg; Pathogen; SAMP

Indexed keywords

CD200 ANTIGEN; CD24 ANTIGEN; CD47 ANTIGEN; CD59 ANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; CRYOPYRIN; CYTOKINE; DECAY ACCELERATING FACTOR; DECTIN 1; DECTIN 2; FRACTALKINE; INTERCELLULAR ADHESION MOLECULE 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NEUROIMMUNE REGULATORY PROTEIN; OPSONIN; PROTEIN TYROSINE KINASE; REGULATOR PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; SCAVENGER RECEPTOR; THY 1 ANTIGEN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ACOUSTIC NERVE FIBER; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CENTRAL NERVOUS SYSTEM; COMPLEMENT SYSTEM; ENDOTHELIUM CELL; EPENDYMA CELL; GLIA CELL; HUMAN; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; NONHUMAN; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; TISSUE REPAIR; VIRUS INFECTION; ANIMAL; GLIA; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; METABOLISM; MOUSE; NERVE CELL; NEURAL STEM CELL; PATHOLOGY; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; MICROGLIA; NERVE DEGENERATION; NEURAL STEM CELLS; NEUROGLIA; NEUROIMMUNOMODULATION; NEURONS;

EID: 79961011276     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152711794488601     Document Type: Article

References (255)

1. Takeuchi, O.; Akira, S. Pattern recognition receptors and inflammation. Cell, 2010, 140(6), 805-820.
2. Hauwel, M.; Furon, E.; Canova, C.; Griffiths, M.; Neal, J.; Gasque, P. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res. Brain Res. Rev., 2005, 48(2), 220-233.
3. Griffiths, M.R.; Gasque, P.; Neal, J.W. The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J. Neuropathol. Exp. Neurol., 2009, 68(3), 217-226.
4. Elward, K.; Gasque, P. "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol. Immunol., 2003, 40(2-4), 85-94.
5. Janeway, C.A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today, 1992, 13(1), 11-16.
6. Matzinger, P. Friendly and dangerous signals: is the tissue in control? Nat. Immunol., 2007, 8(1), 11-13.
7. Gasque, P.; Dean, Y.D.; McGreal, E.P.; VanBeek, J.; Morgan, B.P. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology, 2000, 49(1-2), 171-186.
8. Nguyen, M.D.; Julien, J.P.; Rivest, S. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci., 2002, 3(3), 216-227.
9. Sternberg, E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol., 2006, 6(4), 318-328.
10. Gendelman, H.E. Neural immunity: Friend or foe? J. Neurovirol., 2002, 8(6), 474-479.
11. McGeer, P.L.; McGeer, E.G. Innate immunity, local inflammation, and degenerative disease. Sci. Aging Knowledge Environ., 2002, 2002(29), re3.
12. Minghetti, L. Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol., 2005, 18(3), 315-321.
13. Marin-Teva, J.L.; Dusart, I.; Colin, C.; Gervais, A.; van Rooijen, N.; Mallat, M. Microglia promote the death of developing Purkinje cells. Neuron, 2004, 41(4), 535-547.
14. Elward, K.; Griffiths, M.; Mizuno, M.; Harris, C.L.; Neal, J.W.; Morgan, B.P.; Gasque, P. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem., 2005, 280(43), 36342-36354.
15. Gardai, S.J.; McPhillips, K.A.; Frasch, S.C.; Janssen, W.J.; Starefeldt, A.; Murphy-Ullrich, J.E.; Bratton, D.L.; Oldenborg, P.A.; Michalak, M.; Henson, P.M. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell, 2005, 123(2), 321-334.
16. Glezer, I.; Lapointe, A.; Rivest, S. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J., 2006, 20(6), 750-752.
17. Bsibsi, M.; Persoon-Deen, C.; Verwer, R.W.; Meeuwsen, S.; Ravid, R.; Van Noort, J.M. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia, 2006, 53(7), 688-695.
18. Rahpeymai, Y.; Hiet-aletal/et-ala, M.A.; Wilhelmsson, U.; Fotheringham, A.; Davies, I.; Nilsson, A.K.; Zwirner, J.; Wetsel, R.A.; Gerard, C.; Pekny, M.; Pekna, M. Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J., 2006, 25(6), 1364-1374.
19. Wyss-Coray, T.; Mucke, L. Inflammation in neurodegenerative disease -A double-edged sword. Neuron, 2002, 35(3), 419-432.
20. Wang, J.; Campbell, I.L. Cytokine signaling in the brain: putting a SOCS in it? J. Neurosci. Res., 2002, 67(4), 423-427.
21. Rothlin, C.V.; Ghosh, S.; Zuniga, E.I.; Oldstone, M.B.; Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell, 2007, 131(6), 1124-1136.
22. Griffin, D.E. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol., 2003, 3(6), 493-502.
23. van den Pol, A.N. Viral infections in the developing and mature brain. Trends Neurosci., 2006, 29(7), 398-406.
24. Kraft-Terry, S.D.; Buch, S.J.; Fox, H.S.; Gendelman, H.E. A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron, 2009, 64(1), 133-145.
25. Hanisch, U.K.; Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 2007, 10(11), 1387-1394.
26. Ransohoff, R.M.; Perry, V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol., 2009, 27, 119-145.
27. Morgan, B.P.; Gasque, P. Expression of complement in the brain: role in health and disease. Immunol. Today, 1996, 17(10), 461-466.
28. Bergman, P.; Johansson, L.; Wan, H.; Jones, A.; Gallo, R.L.; Gudmundsson, G.H.; Hokfelt, T.; Jonsson, A.B.; Agerberth, B. Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection. Infect. Immun., 2006, 74(12), 6982-6991.
29. Hao, H.N.; Zhao, J.; Lotoczky, G.; Grever, W.E.; Lyman, W.D. Induction of human beta-defensin-2 expression in human astrocytes by lipopolysaccharide and cytokines. J. Neurochem., 2001, 77(4), 1027-1035.
30. Farina, C.; Aloisi, F.; Meinl, E. Astrocytes are active players in cerebral innate immunity. Trends Immunol., 2007, 28(3), 138-145.
31. Martino, G.; Furlan, R.; Comi, G.; Adorini, L. The ependymal route to the CNS: an emerging gene-therapy approach for MS. Trends Immunol., 2001, 22(9), 483-490.
32. Canova, C.; Neal, J.W.; Gasque, P. Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis. J. Neuroinflammation, 2006, 3(22), 22.
33. Alexopoulou, L.; Holt, A.C.; Medzhitov, R.; Flavell, R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature, 2001, 413(6857), 732-738.
34. Wang, T.; Town, T.; Alexopoulou, L.; Anderson, J.F.; Fikrig, E.; Flavell, R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med., 2004, 10(12), 1366-1373.
35. Daffis, S.; Samuel, M.A.; Suthar, M.S.; Gale, M. Jr.; Diamond, M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol., 2008, 82(21), 10349-10358.
36. Takaoka, A.; Wang, Z.; Choi, M.K.; Yanai, H.; Negishi, H.; Ban, T.; Lu, Y.; Miyagishi, M.; Kodama, T.; Honda, K.; Ohba, Y.; Taniguchi, T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature, 2007, 448(7152), 501-505.
37. Yanai, H.; Savitsky, D.; Tamura, T.; Taniguchi, T. Regulation of the cytosolic DNA-sensing system in innate immunity: a current view. Curr. Opin. Immunol., 2009, 21(1), 17-22.
38. Schroder, K.; Tschopp, J. The inflammasomes. Cell, 2010, 140(6), 821-832.
39. Fujita, T.; Onoguchi, K.; Onomoto, K.; Hirai, R.; Yoneyama, M. Triggering antiviral response by RIG-I-related RNA helicases. Biochimie, 2007, 89(6-7), 754-760.
40. Yoneyama, M.; Kikuchi, M.; Natsukawa, T.; Shinobu, N.; Imaizumi, T.; Miyagishi, M.; Taira, K.; Akira, S.; Fujita, T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol., 2004, 5(7), 730-737.
41. Cavassani, K.A.; Ishii, M.; Wen, H.; Schaller, M.A.; Lincoln, P.M.; Lukacs, N.W.; Hogaboam, C.M.; Kunkel, S.L. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med., 2008, 205(11), 2609-2621.
42. Laflamme, N.; Soucy, G.; Rivest, S. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J. Neurochem., 2001, 79(3), 648-657.
43. Rivest, S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol., 2009, 9(6), 429-439.
44. Balistreri, C.R.; Colonna-Romano, G.; Lio, D.; Candore, G.; Caruso, C. TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J. Clin. Immunol., 2009, 29(4), 406-415.
45. Royet, J.; Dziarski, R. Peptidoglycan recognition proteins: pleiotropic sensors and effectors of antimicrobial defences. Nat. Rev. Microbiol., 2007, 5(4), 264-277.
46. Chauhan, V.S.; Sterka, D.G. Jr.; Furr, S.R.; Young, A.B.; Marriott, I. NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens. Glia, 2009, 57(4), 414-423.
47. Prinz, M.; Garbe, F.; Schmidt, H.; Mildner, A.; Gutcher, I.; Wolter, K.; Piesche, M.; Schroers, R.; Weiss, E.; Kirschning, C.J.; Rochford, C.D.; Bruck, W.; Becher, B. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest., 2006, 116(2), 456-464.
48. Deane, J.A.; Pisitkun, P.; Barrett, R.S.; Feigenbaum, L.; Town, T.; Ward, J.M.; Flavell, R.A.; Bolland, S. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity, 2007, 27(5), 801-810.
49. Paul, S.; Ricour, C.; Sommereyns, C.; Sorgeloos, F.; Michiels, T. Type I interferon response in the central nervous system. Biochimie, 2007, 89(6-7), 770-778.
50. Couderc, T.; Chretien, F.; Schilte, C.; Disson, O.; Brigitte, M.; Guivel-Benhassine, F.; Touret, Y.; Barau, G.; Cayet, N.; Schuffenecker, I.; Despres, P.; Arenzana-Seisdedos, F.; Michault, A.; Albert, M.L.; Lecuit, M. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog., 2008, 4(2), e29.
51. Katze, M.G.; He, Y.; Gale, M. Jr. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol., 2002, 2(9), 675-687.
52. Detje, C.N.; Meyer, T.; Schmidt, H.; Kreuz, D.; Rose, J.K.; Bechmann, I.; Prinz, M.; Kalinke, U. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol., 2009, 182(4), 2297-2304.
53. Tenner, A.J. Membrane Receptors for soluble defense collagens. Curr. Opin. Immunol., 1999, 11, 34-41.
54. Lu, J.; Teh, C.; Kishore, U.; Reid, K.B. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim. Biophys. Acta, 2002, 1572(2-3), 387-400.
55. Zipfel, P.F.; Skerka, C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol., 2009, 9(10), 729-740.
56. Gasque, P. Complement: a unique innate immune sensor for danger signals. Mol. Immunol., 2004, 41(11), 1089-1098.
57. Ehlers, M.R. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect., 2000, 2(3), 289-294.
58. Helmy, K.Y.; Katschke, K.J. Jr.; Gorgani, N.N.; Kljavin, N.M.; Elliott, J.M.; Diehl, L.; Scales, S.J.; Ghilardi, N.; van Lookeren Campagne, M. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006, 124(5), 915-927.
59. Walport, M.J. Complement.First of two parts. N. Engl. J. Med., 2001, 344(14), 1058-1066.
60. Geijtenbeek, T.B.; Gringhuis, S.I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol., 2009, 9(7), 465-479.
61. Burudi, E.M.; Riese, S.; Stahl, P.D.; Regnier-Vigouroux, A. Identification and functional characterisation of the mannose receptor in astrocytes. Glia, 1999, 25(1), 44-55.
62. Mukhopadhyay, S.; Gordon, S. The role of scavenger receptors in pathogen recognition and innate immunity. Immunobiology, 2004, 209(1-2), 39-49.
63. De Witte-Orr, S.J.; Collins, S.E.; Bauer, C.M.; Bowdish, D.M.; Mossman, K.L. An accessory to the 'Trinity': SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Pathog, 2010, 6(3), e1000829.
64. Yamayoshi, S.; Yamashita, Y.; Li, J.; Hanagata, N.; Minowa, T.; Takemura, T.; Koike, S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med., 2009, 15(7), 798-801.
65. Catanese, M.T.; Ansuini, H.; Graziani, R.; Huby, T.; Moreau, M.; Ball, J.K.; Paonessa, G.; Rice, C.M.; Cortese, R.; Vitelli, A.; Nicosia, A. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. J. Virol., 2010, 84(1), 34-43.
66. Herz, J.; Strickland, D.K. LRP: a multifunctional scavenger and signaling receptor. J.Clin. Invest., 2001, 108(6), 779-784.
67. Kovacs, G.G.; Gasque, P.; Strobel, T.; Lindeck-Pozza, E.; Strohschneider, M.; Ironside, J.W.; Budka, H.; Guentchev, M. Complement activation in human prion disease. Neurobiol. Dis., 2004, 15(1), 21-28.
68. Tenner, A.J. Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events. Neurobiol. Aging, 2001, 22(6), 849-861.
69. Rogers, J.; Strohmeyer, R.; Kovelowski, C.J.; Li, R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia, 2002, 40(2), 260-269.
70. Zhang, W.; Wang, T.; Pei, Z.; Miller, D.S.; Wu, X.; Block, M.L.; Wilson, B.; Zhang, W.; Zhou, Y.; Hong, J.S.; Zhang, J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J., 2005, 19(6), 533-542.
71. Ryu, J.K.; Davalos, D.; Akassoglou, K. Fibrinogen signal transduction in the nervous system. J. Thromb. Haemost., 2009, 7(Suppl 1), 151-154.
72. Ryu, J.K.; McLarnon, J.G. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J. Cell Mol. Med., 2009, 13(9A), 2911-2925.
73. Adams, R.A.; Bauer, J.; Flick, M.J.; Sikorski, S.L.; Nuriel, T.; Lassmann, H.; Degen, J.L.; Akassoglou, K. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J. Exp. Med., 2007, 204(3), 571-582.
74. Lee, K.R.; Colon, G.P.; Betz, A.L.; Keep, R.F.; Kim, S.; Hoff, J.T. Edema from intracerebral hemorrhage: the role of thrombin. J. Neurosurg., 1996, 84(1), 91-96.
75. Xi, G.; Reiser, G.; Keep, R.F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J. Neurochem., 2003, 84(1), 3-9.
76. Gingrich, M.B.; Traynelis, S.F. Serine proteases and brain damage -is there a link? Trends Neurosci., 2000, 23(9), 399-407.
77. Ubl, J.J.; Sergeeva, M.; Reiser, G. Desensitisation of protease-activated receptor-1 (PAR-1) in rat astrocytes: evidence for a novel mechanism for terminating Ca2+ signalling evoked by the tethered ligand. J. Physiol., 2000, 525(Pt 2), 319-330.
78. Wang, H.; Reiser, G. Thrombin signaling in the brain: the role of protease-activated receptors. Biol. Chem., 2003, 384(2), 193-202.
79. Weinstein, J.R.; Gold, S.J.; Cunningham, D.D.; Gall, C.M. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci., 1995, 15(4), 2906-2919.
80. Vivien, D.; Buisson, A. Serine protease inhibitors: novel therapeutic targets for stroke? J. Cereb. Blood Flow Metab., 2000, 20(5), 755-764.
81. Docagne, F.; Nicole, O.; Marti, H.H.; MacKenzie, E.T.; Buisson, A.; Vivien, D. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia. FASEB J., 1999, 13(11), 1315-1324.
82. Pindon, A.; Hantai, D.; Jandrot-Perrus, M.; Festoff, B.W. Novel expression and localization of active thrombomodulin on the surface of mouse brain astrocytes. Glia, 1997, 19(3), 259-268.
83. Buisson, A.; Nicole, O.; Docagne, F.; Sartelet, H.; Mackenzie, E.T.; Vivien, D. Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1. FASEB J., 1998, 12(15), 1683-1691.
84. Buisson, A.; Lesne, S.; Docagne, F.; Ali, C.; Nicole, O.; MacKenzie, E.T.; Vivien, D. Transforming growth factor-beta and ischemic brain injury. Cell Mol. Neurobiol., 2003, 23(4-5), 539-550.
85. Cavanaugh, K.P.; Gurwitz, D.; Cunningham, D.D.; Bradshaw, R.A. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem., 1990, 54(5), 1735-1743.
86. Yepes, M.; Sandkvist, M.; Wong, M.K.; Coleman, T.A.; Smith, E.; Cohan, S.L.; Lawrence, D.A. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood, 2000, 96(2), 569-576.
87. Gabriel, C.; Ali, C.; Lesne, S.; Fernandez-Monreal, M.; Docagne, F.; Plawinski, L.; MacKenzie, E.T.; Buisson, A.; Vivien, D. Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J., 2003, 17(2), 277-279.
88. Elliott, M.R.; Chekeni, F.B.; Trampont, P.C.; Lazarowski, E.R.; Kadl, A.; Walk, S.F.; Park, D.; Woodson, R.I.; Ostankovich, M.; Sharma, P.; Lysiak, J.J.; Harden, T.K.; Leitinger, N.; Ravichandran, K.S. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature, 2009, 461(7261), 282-286.
89. Ghiringhelli, F.; Apetoh, L.; Tesniere, A.; Aymeric, L.; Ma, Y.; Ortiz, C.; Vermaelen, K.; Panaretakis, T.; Mignot, G.; Ullrich, E.; Perfettini, J.L.; Schlemmer, F.; Tasdemir, E.; Uhl, M.; Genin, P.; Civas, A.; Ryffel, B.; Kanellopoulos, J.; Tschopp, J.; Andre, F.; Lidereau, R.; McLaughlin, N.M.; Haynes, N.M.; Smyth, M.J.; Kroemer, G.; Zitvogel, L. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med., 2009, 15(10), 1170-8.
90. Skaper, S.D.; Debetto, P.; Giusti, P. The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J., 2010, 24(2), 337-45.
91. Fassbender, K.; Walter, S.; Kuhl, S.; Landmann, R.; Ishii, K.; Bertsch, T.; Stalder, A.K.; Muehlhauser, F.; Liu, Y.; Ulmer, A.J.; Rivest, S.; Lentschat, A.; Gulbins, E.; Jucker, M.; Staufenbiel, M.; Brechtel, K.; Walter, J.; Multhaup, G.; Penke, B.; Adachi, Y.; Hartmann, T.; Beyreuther, K. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J., 2004, 18(1), 203-5.
92. Tahara, K.; Kim, H.D.; Jin, J.J.; Maxwell, J.A.; Li, L.; Fukuchi, K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain, 2006, 129(Pt 11), 3006-3019.
93. El Khoury, J.B.; Moore, K.J.; Means, T.K.; Leung, J.; Terada, K.; Toft, M.; Freeman, M.W.; Luster, A.D. CD36 mediates the innate host response to beta-amyloid. J. Exp. Med., 2003, 197(12), 1657-1666.
94. Landreth, G.E.; Reed-Geaghan, E.G. Toll-like receptors in Alzheimer's disease. Curr. Top. Microbiol. Immunol., 2009, 336, 137-153.
95. Salminen, A.; Ojala, J.; Suuronen, T.; Kaarniranta, K.; Kauppinen, A. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J. Cell Mol. Med., 2008, 12(6A), 2255-2262.
96. Reed-Geaghan, E.G.; Savage, J.C.; Hise, A.G.; Landreth, G.E. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J. Neurosci., 2009, 29(38), 11982-11992.
97. Walter, S.; Letiembre, M.; Liu, Y.; Heine, H.; Penke, B.; Hao, W.; Bode, B.; Manietta, N.; Walter, J.; Schulz-Schuffer, W.; Fassbender, K. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol. Biochem., 2007, 20(6), 947-956.
98. Jin, J.J.; Kim, H.D.; Maxwell, J.A.; Li, L.; Fukuchi, K. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J. Neuroinflammation, 2008, 5, 23.
99. Minoretti, P.; Gazzaruso, C.; Vito, C.D.; Emanuele, E.; Bianchi, M.; Coen, E.; Reino, M.; Geroldi, D. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci. Lett., 2006, 391(3), 147-149.
100. Chen, K.; Iribarren, P.; Hu, J.; Chen, J.; Gong, W.; Cho, E.H.; Lockett, S.; Dunlop, N.M.; Wang, J.M. Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J. Biol. Chem., 2006, 281(6), 3651-3659.
101. Jana, M.; Palencia, C.A.; Pahan, K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease. J. Immunol., 2008, 181(10), 7254-7262.
102. Richard, K.L.; Filali, M.; Prefontaine, P.; Rivest, S. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci., 2008, 28(22), 5784-5793
103. Halle, A.; Hornung, V.; Petzold, G.C.; Stewart, C.R.; Monks, B.G.; Reinheckel, T.; Fitzgerald, K.A.; Latz, E.; Moore, K.J.; Golenbock, D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol., 2008, 9(8), 857-865.
104. Jiang, H.; Burdick, D.; Glabe, C.G.; Cotman, C.W.; Tenner, A.J. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol., 1994, 152(10), 5050-5059.
105. McGeer, P.L.; Akiyama, H.; Itagaki, S.; McGeer, E.G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett., 1989, 107(1-3), 341-346.
106. Eikelenboom, P.; Bate, C.; Van Gool, W.A.; Hoozemans, J.J.; Rozemuller, J.M.; Veerhuis, R.; Williams, A. Neuroinflammation in Alzheimer's disease and prion disease. Glia, 2002, 40(2), 232-239.
107. Singhrao S.K.; Neal, J.W.; Gasque, P.; Newman, G.R. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's Disease. Exp. Neurol., 1999, 159, 362-376.
108. Yasuhara, O.; Aimi, Y.; McGeer, E.G.; McGeer, P.L. Expression of the complement membrane attack complex and its inhibitors in Pick disease brain. Brain Res., 1994, 652(2), 346-349.
109. Kertesz, A.; Munoz, D.G. In: Pick's Disease and Pick Complex; Wiley-Liss; NY, 1998.
110. van Beek, J.; Nicole, O.; Ali, C.; Ischenko, A.; MacKenzie, E.T.; Buisson, A.; Fontaine, M. Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport, 2001, 12(2), 289-293.
111. Van Beek, J.; Bernaudin, M.; Petit, E.; Gasque, P.; Nouvelot, A.; MacKenzie, E.T.; Fontaine, M. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp. Neurol., 2000, 161(1), 373-382.
112. Barnum, S.R.; Ames, R.S.; Maycox, P.R.; Hadingham, S.J.; Meakin, J.; Harrison, D.; Parsons, A.A. Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretation. Glia, 2002, 38(2), 169-173.
113. De Simoni, M.G.; Rossi, E.; Storini, C.; Pizzimenti, S.; Echart, C.; Bergamaschini, L. The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q. Am. J. Pathol., 2004, 164(5), 1857-1863.
114. Yan, S.D.; Bierhaus, A.; Nawroth, P.P.; Stern, D.M. RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation? J. Alzheimers Dis., 2009, 16(4), 833-843.
115. Yan, S.D.; Chen, X.; Fu, J.; Chen, M.; Zhu, H.; Roher, A.; Slattery, T.; Zhao, L.; Nagashima, M.; Morser, J.; Migheli, A.; Nawroth, P.; Stern, D.; Schmidt, A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature, 1996, 382(6593), 685-691.
116. Origlia, N.; Righi, M.; Capsoni, S.; Cattaneo, A.; Fang, F.; Stern, D.M.; Chen, J.X.; Schmidt, A.M.; Arancio, O.; Yan, S.D.; Domenici, L. Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction. J. Neurosci., 2008, 28(13), 3521-3530.
117. Takuma, K.; Fang, F.; Zhang, W.; Yan, S.; Fukuzaki, E.; Du, H.; Sosunov, A.; McKhann, G.; Funatsu, Y.; Nakamichi, N.; Nagai, T.; Mizoguchi, H.; Ibi, D.; Hori, O.; Ogawa, S.; Stern, D.M.; Yamada, K.; Yan, S.S. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc. Natl. Acad. Sci. USA, 2009, 106(47), 20021-20026.
118. Takeuchi, M.; Yamagishi, S. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease. J. Alzheimers Dis., 2009, 16(4), 845-858.
119. Kalaria, R.N. Neurodegenerative disease: Diabetes, microvascular pathology and Alzheimer disease. Nat. Rev. Neurol., 2009, 5(6), 305-306.
120. Bu, G.; Cam, J.; Zerbinatti, C. LRP in amyloid-beta production and metabolism. Ann. NY Acad. Sci., 2006, 1086, 35-53.
121. Spencer, B.; Potkar, R.; Trejo, M.; Rockenstein, E.; Patrick, C.; Gindi, R.; Adame, A.; Wyss-Coray, T.; Masliah, E. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci., 2009, 29(43), 13578-13588.
122. Lotze, M.T.; Tracey, K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol., 2005, 5(4), 331-342.
123. Roth, J.; Vogl, T.; Sorg, C.; Sunderkotter, C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol., 2003, 24(4), 155-158.
124. Foell, D.; Wittkowski, H.; Vogl, T.; Roth, J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol., 2007, 81(1), 28-37.
125. Zitvogel, L.; Kepp, O.; Kroemer, G. Decoding cell death signals in inflammation and immunity. Cell, 2010, 140(6), 798-804.
126. Abeyama, K.; Stern, D.M.; Ito, Y.; Kawahara, K.; Yoshimoto, Y.; Tanaka, M.; Uchimura, T.; Ida, N.; Yamazaki, Y.; Yamada, S.; Yamamoto, Y.; Yamamoto, H.; Iino, S.; Taniguchi, N.; Maruyama, I. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Invest., 2005, 115(5), 1267-1274.
127. Yamasaki, S.; Ishikawa, E.; Sakuma, M.; Hara, H.; Ogata, K.; Saito, T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol., 2008, 9(10), 1179-1188.
128. Gregory, C.D.; Devitt, A. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology, 2004, 113(1), 1-14.
129. Fadok V.A, B.D.L. Rose D.M, Pearson A, Ezekewitz A.B, Henson P.M, A receptor for phosphatidylserine specific clearance of apoptotic cells. Nature, 2000, 405, 85-90.
130. Fadok VA, B.D. Rose DM, Pearson A, Ezekewitz RA, Henson PM, A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature, 2000, 405(6782), 85-90.
131. Hanayama, R.; Tanaka, M.; Miwa, K.; Shinohara, A.; Iwamatsu, A.; Nagata, S. Identification of a factor that links apoptotic cells to phagocytes. Nature, 2002, 417(6885), 182-187.
132. Gregory, C.D. CD14 dependent clearance of apoptotic cells: relevance to the immune system. Curr. Opin. Immunol., 2000, 12, 27-34.
133. Fadok V.A, W.M. Bratton DL, Henson PM, CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J. Immunol., 1998, 161(11), 6350-6357.
134. Leonardi-Essmann, F.; Emig, M.; Kitamura, Y.; Spanagel, R.; Gebicke-Haerter, P.J. Fractalkine-upregulated milk-fat globule EGF factor-8 protein in cultured rat microglia. J. Neuroimmunol., 2005, 160(1-2), 92-101.
135. De Simone, R.; Ajmone-Cat, M.A.; Minghetti, L. Atypical antiinflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol. Neurobiol., 2004, 29(2), 197-212.
136. Lemke, G.; Rothlin, C.V. Immunobiology of the TAM receptors. Nat. Rev. Immunol., 2008, 8(5), 327-336.
137. Prieto, A.L.; Weber, J.L.; Tracy, S.; Heeb, M.J.; Lai, C. Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system. Brain Res., 1999, 816(2), 646-661.
138. Prieto, A.L.; Weber, J.L.; Lai, C. Expression of the receptor protein-tyrosine kinases Tyro-3, Axl, and mer in the developing rat central nervous system. J. Comp. Neurol., 2000, 425(2), 295-314.
139. Weinger, J.G.; Omari, K.M.; Marsden, K.; Raine, C.S.; Shafit-Zagardo, B. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. Am. J. Pathol., 2009, 175(1), 283-293.
140. Yagami, T.; Ueda, K.; Asakura, K.; Okamura, N.; Sakaeda, T.; Sakaguchi, G.; Itoh, N.; Hashimoto, Y.; Nakano, T.; Fujimoto, M. Effect of Gas6 on secretory phospholipase A(2)-IIA-induced apoptosis in cortical neurons. Brain Res., 2003, 985(2), 142-149.
141. Yagami, T.; Ueda, K.; Asakura, K.; Sakaeda, T.; Nakazato, H.; Kuroda, T.; Hata, S.; Sakaguchi, G.; Itoh, N.; Nakano, T.; Kambayashi, Y.; Tsuzuki, H. Gas6 rescues cortical neurons from amyloid beta protein-induced apoptosis. Neuropharmacology, 2002, 43(8), 1289-1296.
142. Li, M.O.; Sarkisian, M.R.; Mehal, W.Z.; Rakic, P.; Flavell, R.A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science, 2003, 302(5650), 1560-1563.
143. Korb, L.C.; Ahearn, J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol., 1997, 158(10), 4525-4528.
144. Savill, J.; Dransfield, I.; Gregory, C.; Haslett, C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol., 2002, 2(12), 965-975.
145. Everett, H.; McFadden, G. Apoptosis: an innate immune response to virus infection. Trends Microbiol., 1999, 7(4), 160-165.
146. Popovich, P.G.; Longbrake, E.E. Can the immune system be harnessed to repair the CNS? Nat. Rev. Neurosci., 2008, 9(6), 481-493.
147. Streit, W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia, 2002, 40(2), 133-139.
148. Kigerl, K.A.; Gensel, J.C.; Ankeny, D.P.; Alexander, J.K.; Donnelly, D.J.; Popovich, P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci., 2009, 29(43), 13435-13444.
149. Foster-Cuevas, M.; Wright, G.J.; Puklavec, M.J.; Brown, M.H.; Barclay, A.N. Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J. Virol., 2004, 78(14), 7667-7676.
150. Cameron, C.M.; Barrett, J.W.; Mann, M.; Lucas, A.; McFadden, G. Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology, 2005, 337(1), 55-67.
151. Griffiths, M.; Neal, J.W.; Gasque, P. Innate immunity and protective neuroinflammation: New emphasis on the role of neuroimmune regulatory proteins (NIRegs). Int. Rev. Neurobiol., 2007, 82, 29-55.
152. Cerwenka, A.; Lanier, L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol., 2001, 1(1), 41-49.
153. Sjoberg, A.P.; Trouw, L.A.; Blom, A.M. Complement activation and inhibition: a delicate balance. Trends Immunol., 2009, 30(2), 83-90.
154. Griffiths, M.R.; Neal, J.W.; Fontaine, M.; Das, T.; Gasque, P. Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. J. Immunol., 2009, 182(7), 4368-4377.
155. Hamann, J.; Vogel, B.; van Schijndel, G.M.; van Lier, R.A. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med., 1996, 184(3), 1185-1189.
156. Trouw, L.A.; Nilsson, S.C.; Goncalves, I.; Landberg, G.; Blom, A.M. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med., 2005, 201(12), 1937-1948.
157. Wang, S.M.; Yang, W.L. Circulating hormone adrenomedullin and its binding protein protect neural cells from hypoxia-induced apoptosis. Biochim. Biophys. Acta, 2009, 1790(5), 361-367.
158. Leffler, J.; Herbert, A.P.; Norstrom, E.; Schmidt, C.Q.; Barlow, P.N.; Blom, A.M.; Martin, M. Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells. J. Biol. Chem., 2010, 285(6), 3766-3776.
159. Meri, S.; Pangburn, M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA, 1990, 87(10), 3982-3986.
160. Crocker, P.R. Siglecs in innate immunity. Curr. Opin. Pharmacol., 2005, 5(4), 431-437.
161. Lock, K.; Zhang, J.; Lu, J.; Lee, S.H.; Crocker, P.R. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology, 2004, 209(1-2), 199-207.
162. Jones, C.; Virji, M.; Crocker, P.R. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol., 2003, 49(5), 1213-1225.
163. Angata, T.; Kerr, S.C.; Greaves, D.R.; Varki, N.M.; Crocker, P.R.; Varki, A. Cloning and characterization of human Siglec-11.A recently evolved signaling that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J. Biol. Chem., 2002, 277(27), 24466-24474.
164. Mott, R.T.; Ait-Ghezala, G.; Town, T.; Mori, T.; Vendrame, M.; Zeng, J.; Ehrhart, J.; Mullan, M.; Tan, J. Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia, 2004, 46(4), 369-379.
165. Brown, E.J.; Frazier, W.A. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol., 2001, 11(3), 130-135.
166. Barclay, A.N.; Wright, G.J.; Brooke, G.; Brown, M.H. CD200 and membrane protein E interactions in the control of myeloid cells. Trends Immunol., 2002, 23(6), 285-290.
167. Hoek, R.M.; Ruuls, S.R.; Murphy, C.A.; Wright, G.J.; Goddard, R.; Zurawski, S.M.; Blom, B.; Homola, M.E.; Streit, W.J.; Brown, M.H.; Barclay, A.N.; Sedgwick, J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science, 2000, 290(5497), 1768.
168. Wright, G.J.; Jones, M.; Puklavec, M.J.; Brown, M.H.; Barclay, A.N. The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology, 2001, 102(2), 173-179.
169. Koning, N.; Swaab, D.F.; Hoek, R.M.; Huitinga, I. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. J. Neuropathol. Exp. Neurol., 2009, 68(2), 159-167.
170. Broderick, C.; Hoek, R.M.; Forrester, J.V.; Liversidge, J.; Sedgwick, J.D.; Dick, A.D. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol., 2002, 161(5), 1669-1677.
171. Sergent-Tanguy, S.; Veziers, J.; Bonnamain, V.; Boudin, H.; Neveu, I.; Naveilhan, P. Cell surface antigens on rat neural progenitors and characterization of the CD3 (+)/CD3 (-) cell populations. Differentiation, 2006, 74(9-10), 530-541.
172. Lyons, A.; Downer, E.J.; Crotty, S.; Nolan, Y.M.; Mills, K.H.; Lynch, M.A. CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J. Neurosci., 2007, 27(31), 8309-8313.
173. Walker, D.G.; Dalsing-Hernandez, J.E.; Campbell, N.A.; Lue, L.F. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation. Exp. Neurol., 2009, 215(1), 5-19.
174. de Vries, H.E.; Hendriks, J.J.; Honing, H.; De Lavalette, C.R.; van der Pol, S.M.; Hooijberg, E.; Dijkstra, C.D.; van den Berg, T.K. Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J. Immunol., 2002, 168(11), 5832-5839.
175. Reinhold, M.I.; Lindberg, F.P.; Plas, D.; Reynolds, S.; Peters, M.G.; Brown, E.J. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J. Cell Sci., 1995, 108(Pt 11), 3419-3425.
176. Oldenborg, P.A.; Gresham, H.D.; Lindberg, F.P. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J. Exp. Med., 2001, 193(7), 855-862.
177. Vernon-Wilson, E.F.; Kee, W.J.; Willis, A.C.; Barclay, A.N.; Simmons, D.L.; Brown, M.H. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1. Eur. J. Immunol., 2000, 30(8), 2130-2137.
178. Seiffert, M.; Brossart, P.; Cant, C.; Cella, M.; Colonna, M.; Brugger, W.; Kanz, L.; Ullrich, A.; Buhring, H.J. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. Blood, 2001, 97(9), 2741-2749.
179. Murata, T.; Ohnishi, H.; Okazawa, H.; Murata, Y.; Kusakari, S.; Hayashi, Y.; Miyashita, M.; Itoh, H.; Oldenborg, P.A.; Furuya, N.; Matozaki, T. CD47 promotes neuronal development through Src-and FRG/Vav2-mediated activation of Rac and Cdc42. J. Neurosci., 2006, 26(48), 12397-12407.
180. Bamberger, M.E.; Harris, M.E.; McDonald, D.R.; Husemann, J.; Landreth, G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci., 2003, 23(7), 2665-2674.
181. Chen, G.Y.; Tang, J.; Zheng, P.; Liu, Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science, 2009, 323(5922), 1722-1725.
182. Shewan, D.; Calaora, V.; Nielsen, P.; Cohen, J.; Rougon, G.; Moreau, H. mCD24, a glycoprotein transiently expressed by neurons, is an inhibitor of neurite outgrowth. J. Neurosci., 1996, 16(8), 2624-2634.
183. Kleene, R.; Yang, H.; Kutsche, M.; Schachner, M. The neural recognition molecule L1 is a sialic acid-binding lectin for CD24, which induces promotion and inhibition of neurite outgrowth. J. Biol. Chem., 2001, 276(24), 21656-21663.
184. Nieoullon, V.; Belvindrah, R.; Rougon, G.; Chazal, G. mCD24 regulates proliferation of neuronal committed precursors in the subventricular zone. Mol. Cell Neurosci., 2005, 28(3), 462-474.
185. Belvindrah, R.; Rougon, G.; Chazal, G. Increased neurogenesis in adult mCD24-deficient mice. J. Neurosci., 2002, 22(9), 3594-3607.
186. Cardona, A.E.; Pioro, E.P.; Sasse, M.E.; Kostenko, V.; Cardona, S.M.; Dijkstra, I.M.; Huang, D.; Kidd, G.; Dombrowski, S.; Dutta, R.; Lee, J.C.; Cook, D.N.; Jung, S.; Lira, S.A.; Littman, D.R.; Ransohoff, R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci., 2006, 9(7), 917-924.
187. Ly, N.P.; Komatsuzaki, K.; Fraser, I.P.; Tseng, A.A.; Prodhan, P.; Moore, K.J.; Kinane, T.B. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 2005, 102(41), 14729-14734.
188. Rosenberger, P.; Schwab, J.M.; Mirakaj, V.; Masekowsky, E.; Mager, A.; Morote-Garcia, J.C.; Unertl, K.; Eltzschig, H.K. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol., 2009, 10(2), 195-202.
189. Suzuki, K.; Okuno, T.; Yamamoto, M.; Pasterkamp, R.J.; Takegahara, N.; Takamatsu, H.; Kitao, T.; Takagi, J.; Rennert, P.D.; Kolodkin, A.L.; Kumanogoh, A.; Kikutani, H. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature, 2007, 446(7136), 680-684.
190. Carpentier, P.A.; Palmer, T.D. Immune influence on adult neural stem cell regulation and function. Neuron, 2009, 64(1), 79-92.
191. Covacu, R.; Arvidsson, L.; Andersson, A.; Khademi, M.; Erlandsson-Harris, H.; Harris, R.A.; Svensson, M.A.; Olsson, T.; Brundin, L. TLR activation induces TNF-alpha production from adult neural stem/progenitor cells. J. Immunol., 2009, 182(11), 6889-6895.
192. Rolls, A.; Shechter, R.; London, A.; Ziv, Y.; Ronen, A.; Levy, R.; Schwartz, M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol., 2007, 9(9), 1081-1088.
193. Shechter, R.; Ronen, A.; Rolls, A.; London, A.; Bakalash, S.; Young, M.J.; Schwartz, M. Toll-like receptor 4 restricts retinal progenitor cell proliferation. J. Cell Biol., 2008, 183(3), 393-400.
194. Ekdahl, C.T.; Claasen, J.H.; Bonde, S.; Kokaia, Z.; Lindvall, O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA, 2003, 100(23), 13632-13637.
195. Monje, M.L.; Toda, H.; Palmer, T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science, 2003, 302(5651), 1760-1765.
196. Setzu, A.; Lathia, J.D.; Zhao, C.; Wells, K.; Rao, M.S.; Ffrench-Constant, C.; Franklin, R.J. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia, 2006, 54(4), 297-303.
197. Fischer, W.H.; Hugli, T.E. Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response. J. Immunol., 1997, 159(9), 4279-4286.
198. Boos, L.; Szalai, A.J.; Barnum, S.R. C3a expressed in the central nervous system protects against LPS-induced shock. Neurosci. Lett., 2005, 387(2), 68-71.
199. Francis, K.; Lewis, B.M.; Akatsu, H.; Monk, P.N.; Cain, S.A.; Scanlon, M.F.; Morgan, B.P.; Ham, J.; Gasque, P. Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J., 2003, 17(15), 2266-2268.
200. Shinjyo, N.; Stahlberg, A.; Dragunow, M.; Pekny, M.; Pekna, M. Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells. Stem Cells, 2009, 27(11), 2824-2832.
201. Lucin, K.M.; Wyss-Coray, T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron, 2009, 64(1), 110-122.
202. Soulet, D.; Rivest, S. Bone-marrow-derived microglia: myth or reality? Curr. Opin. Pharmacol., 2008, 8(4), 508-518.
203. Simard, A.R.; Soulet, D.; Gowing, G.; Julien, J.P.; Rivest, S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron, 2006, 49(4), 489-502.
204. Takahashi, K.; Prinz, M.; Stagi, M.; Chechneva, O.; Neumann, H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med., 2007, 4(4), e124.
205. Ayaz, D.; Leyssen, M.; Koch, M.; Yan, J.; Srahna, M.; Sheeba, V.; Fogle, K.J.; Holmes, T.C.; Hassan, B.A. Axonal injury and regeneration in the adult brain of Drosophila. J. Neurosci., 2008, 28(23), 6010-6021.
206. Laflamme, N.; Rivest, S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J., 2001, 15(1), 155-163.
207. Laflamme, N.; Echchannaoui, H.; Landmann, R.; Rivest, S. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria. Eur. J. Immunol., 2003, 33(4), 1127-1138.
208. Olson, J.K.; Miller, S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol., 2004, 173(6), 3916-3924.
209. Babcock, A.A.; Wirenfeldt, M.; Holm, T.; Nielsen, H.H.; Dissing-Olesen, L.; Toft-Hansen, H.; Millward, J.M.; Landmann, R.; Rivest, S.; Finsen, B.; Owens, T. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci., 2006, 26(49), 12826-12837.
210. Bsibsi, M.; Ravid, R.; Gveric, D.; van Noort, J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol., Exp. Neurol., 2002, 61(11), 1013-1021.
211. Cameron, J.S.; Alexopoulou, L.; Sloane, J.A.; DiBernardo, A.B.; Ma, Y.; Kosaras, B.; Flavell, R.; Strittmatter, S.M.; Volpe, J.; Sidman, R.; Vartanian, T. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci., 2007, 27(47), 13033-13041.
212. Gorina, R.; Santalucia, T.; Petegnief, V.; Ejarque-Ortiz, A.; Saura, J.; Planas, A.M. Astrocytes are very sensitive to develop innate immune responses to lipid-carried short interfering RNA. Glia, 2009, 57(1), 93-107.
213. Bowman, C.C.; Rasley, A.; Tranguch, S.L.; Marriott, I. Cultured astrocytes express toll-like receptors for bacterial products. Glia, 2003, 43(3), 281-291.
214. Carpentier, P.A.; Begolka, W.S.; Olson, J.K.; Elhofy, A.; Karpus, W.J.; Miller, S.D. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia, 2005, 49(3), 360-374.
215. Carpentier, P.A.; Duncan, D.S.; Miller, S.D. Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav. Immun., 2008, 22(2), 140-147.
216. Carpentier, P.A.; Williams, B.R.; Miller, S.D. Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia, 2007, 55(3), 239-252.
217. McKimmie, C.S.; Fazakerley, J.K. In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J. Neuroimmunol., 2005, 169(1-2), 116-125.
218. McKimmie, C.S.; Roy, D.; Forster, T.; Fazakerley, J.K. Innate immune response gene expression profiles of N9 microglia are pathogen-type specific. J. Neuroimmunol., 2006, 175(1-2), 128-141.
219. Chung, K.M.; Liszewski, M.K.; Nybakken, G.; Davis, A.E.; Townsend, R.R.; Fremont, D.H.; Atkinson, J.P.; Diamond, M.S. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl. Acad. Sci. USA, 2006, 103(50), 19111-19116.
220. Bottcher, T.; von Mering, M.; Ebert, S.; Meyding-Lamade, U.; Kuhnt, U.; Gerber, J.; Nau, R. Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections. Neurosci. Lett., 2003, 344(1), 17-20.
221. Lathia, J.D.; Okun, E.; Tang, S.C.; Griffioen, K.; Cheng, A.; Mughal, M.R.; Laryea, G.; Selvaraj, P.K.; ffrench-Constant, C.; Magnus, T.; Arumugam, T.V.; Mattson, M.P. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J. Neurosci., 2008, 28(51), 13978-13984.
222. Jackson, A.C.; Rossiter, J.P.; Lafon, M. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J. Neurovirol., 2006, 12(3), 229-234.
223. Prehaud, C.; Megret, F.; Lafage, M.; Lafon, M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol., 2005, 79(20), 12893-12904.
224. Farina, C.; Krumbholz, M.; Giese, T.; Hartmann, G.; Aloisi, F.; Meinl, E. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol., 2005, 159(1-2), 12-19.
225. Rivieccio, M.A.; Suh, H.S.; Zhao, Y.; Zhao, M.L.; Chin, K.C.; Lee, S.C.; Brosnan, C.F. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J. Immunol., 2006, 177(7), 4735-4741.
226. Nishimura, M.; Naito, S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol. Pharm. Bull., 2005, 28(5), 886-892.
227. Jack, C.S.; Arbour, N.; Manusow, J.; Montgrain, V.; Blain, M.; McCrea, E.; Shapiro, A.; Antel, J.P. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol., 2005, 175(7), 4320-4330.
228. Chakravarty, S.; Herkenham, M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci., 2005, 25(7), 1788-1796.
229. Lehnardt, S.; Massillon, L.; Follett, P.; Jensen, F.E.; Ratan, R.; Rosenberg, P.A.; Volpe, J.J.; Vartanian, T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA, 2003, 100(14), 8514-8519.
230. Jung, D.Y.; Lee, H.; Jung, B.Y.; Ock, J.; Lee, M.S.; Lee, W.H.; Suk, K. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J. Immunol., 2005, 174(10), 6467-6476.
231. Butchi, N.B.; Pourciau, S.; Du, M.; Morgan, T.W.; Peterson, K.E. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists. J. Immunol., 2008, 180(11), 7604-7612.
232. Letiembre, M.; Hao, W.; Liu, Y.; Walter, S.; Mihaljevic, I.; Rivest, S.; Hartmann, T.; Fassbender, K. Innate immune receptor expression in normal brain aging. Neuroscience, 2007, 146(1), 248-254.
233. Mishra, B.B.; Mishra, P.K.; Teale, J.M. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J. Neuroimmunol., 2006, 181(1-2), 46-56.
234. Ma, Y.; Haynes, R.L.; Sidman, R.L.; Vartanian, T. TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle, 2007, 6(23), 2859-2868.
235. Ma, Y.; Li, J.; Chiu, I.; Wang, Y.; Sloane, J.A.; Lu, J.; Kosaras, B.; Sidman, R.L.; Volpe, J.J.; Vartanian, T. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol., 2006, 175(2), 209-215.
236. Dalpke, A.H.; Schafer, M.K.; Frey, M.; Zimmermann, S.; Tebbe, J.; Weihe, E.; Heeg, K. Immunostimulatory CpG-DNA activates murine microglia. J. Immunol., 2002, 168(10), 4854-4863.
237. Iliev, A.I.; Stringaris, A.K.; Nau, R.; Neumann, H. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J., 2004, 18(2), 412-414.
238. Furr, S.R.; Chauhan, V.S.; Sterka, D. Jr.; Grdzelishvili, V.; Marriott, I. Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus. J. Neurovirol., 2008, 1-11.
239. De Miranda, J.; Yaddanapudi, K.; Hornig, M.; Lipkin, W.I. Astrocytes recognize intracellular polyinosinic-polycytidylic acid via MDA-5. FASEB J., 2009, 23(4), 1064-1071.
240. Yoshida, H.; Imaizumi, T.; Lee, S.J.; Tanji, K.; Sakaki, H.; Matsumiya, T.; Ishikawa, A.; Taima, K.; Yuzawa, E.; Mori, F.; Wakabayashi, K.; Kimura, H.; Satoh, K. Retinoic acid-inducible gene-I mediates RANTES/CCL5 expression in U373MG human astrocytoma cells stimulated with double-stranded RNA. Neurosci. Res., 2007, 58(2), 199-206.
241. Sterka, D. Jr.; Marriott, I. Characterization of nucleotide-binding oligomerization domain (NOD) protein expression in primary murine microglia. J. Neuroimmunol., 2006, 179(1-2), 65-75.
242. Sterka, D. Jr.; Rati, D.M.; Marriott, I. Functional expression of NOD2, a novel pattern recognition receptor for bacterial motifs, in primary murine astrocytes. Glia, 2006, 53(3), 322-330.
243. Hornung, V.; Ablasser, A.; Charrel-Dennis, M.; Bauernfeind, F.; Horvath, G.; Caffrey, D.R.; Latz, E.; Fitzgerald, K.A. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature, 2009, 458(7237), 514-518.
244. Shah, V.B.; Huang, Y.; Keshwara, R.; Ozment-Skelton, T.; Williams, D.L.; Keshvara, L. Beta-glucan activates microglia without inducing cytokine production in Dectin-1-dependent manner. J. Immunol., 2008, 180(5), 2777-2785.
245. Shah, V.B.; Williams, D.L.; Keshvara, L. beta-Glucan attenuates TLR2-and TLR4-mediated cytokine production by microglia. Neurosci. Lett., 2009, 458(3), 111-115.
246. Hadas, S.; Reichert, F.; Rotshenker, S. Dissimilar and similar functional properties of complement receptor-3 in microglia and macrophages in combating yeast pathogens by phagocytosis. Glia, 2010, 58(7), 823-830.
247. Holtzman, D.M.; Pitas, R.E.; Kilbridge, J.; Nathan, B.; Mahley, R.W.; Bu, G.; Schwartz, A.L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA, 1995, 92(21), 9480-9484.
248. Deane, R.; Wu, Z.; Sagare, A.; Davis, J.; Du Yan, S.; Hamm, K.; Xu, F.; Parisi, M.; LaRue, B.; Hu, H.W.; Spijkers, P.; Guo, H.; Song, X.; Lenting, P.J.; Van Nostrand, W.E.; Zlokovic, B.V. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron, 2004, 43(3), 333-344.
249. Du Yan, S.; Zhu, H.; Fu, J.; Yan, S.F.; Roher, A.; Tourtellotte, W.W.; Rajavashisth, T.; Chen, X.; Godman, G.C.; Stern, D.; Schmidt, A.M. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA, 1997, 94(10), 5296-5301.
250. Sasaki, N.; Toki, S.; Chowei, H.; Saito, T.; Nakano, N.; Hayashi, Y.; Takeuchi, M.; Makita, Z. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res., 2001, 888(2), 256-262.
251. Ma, L.; Carter, R.J.; Morton, A.J.; Nicholson, L.F. RAGE is expressed in pyramidal cells of the hippocampus following moderate hypoxic-ischemic brain injury in rats. Brain Res., 2003, 966(2), 167-174.
252. Bianchi, R.; Adami, C.; Giambanco, I.; Donato, R. S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol., 2007, 81(1), 108-118.
253. Fang, F.; Lue, L.F.; Yan, S.; Xu, H.; Luddy, J.S.; Chen, D.; Walker, D.G.; Stern, D.M.; Yan, S.; Schmidt, A.M.; Chen, J.X.; Yan, S.S. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J., 2010, 24(4), 1043-1055.
254. Coraci IS, H.J. Berman JW, Hulette C, Dufour JH, Campanella GK, Luster AD, Silverstein SC, El Khoury JB, CD36, a Class B Scavenger Receptor, Is expressed on Microglia in Alzheimer's Disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol., 2002, 160(1), 101-112.
255. Husemann, J.; Loike, J.D.; Anankov, R.; Febbraio, M.; Silverstein, S.C. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia, 2002, 40(2), 195-205.